No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
ANVS Annovis Bio
- 2.730
- +0.130+5.00%
Close Feb 14 16:00 ET
- 2.740
- +0.010+0.36%
Post 20:01 ET
53.20MMarket Cap-0.65P/E (TTM)
2.790High2.610Low506.47KVolume2.650Open2.600Pre Close1.37MTurnover3.23%Turnover RatioLossP/E (Static)19.49MShares20.00052wk High7.52P/B42.78MFloat Cap2.44052wk Low--Dividend TTM15.67MShs Float132.000Historical High--Div YieldTTM6.92%Amplitude2.418Historical Low2.703Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
D. Boral Capital Downgrades Annovis Bio(ANVS.US) to Hold Rating
D. Boral Capital Downgrades Annovis Bio to Hold
Annovis Bio Analyst Ratings
Annovis to Present at Oppenheimer's 35th Annual Healthcare Life Sciences Conference
Annovis Bio Announces That The First Two Patients Have Been Entered Into The Phase 3 Study Evaluating Buntanetap In Early AD
Annovis Announces First Patients Entered Into Pivotal Phase 3 Study of Buntanetap for Early Alzheimer's Disease
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Log In for the Full List
Unlock Now